Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Mar 9, 2011 goldstein joseph l Director Option Execute 15,000 9.17
Mar 21, 2011 goldstein joseph l Director Automatic Sell 11,505 40.00
Dec 16, 2010 goldstein joseph l Director Automatic Sell 4,719 31.80
Dec 17, 2010 goldstein joseph l Director Automatic Sell 5,281 32.00
Dec 16, 2010 goldstein joseph l Director Option Execute 10,000 15.01
Jan 26, 2011 goldstein joseph l Director Automatic Sell 4,599 34.35
Jan 27, 2011 goldstein joseph l Director Automatic Sell 5,401 34.67
Jan 26, 2011 goldstein joseph l Director Option Execute 10,000 15.80
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
Oct 4, 2010 goldstein joseph l Director Option Execute 10,000 18.80
Oct 5, 2010 goldstein joseph l Director Automatic Sell 3,152 28.40
Nov 23, 2010 goldstein joseph l Director Automatic Sell 5,669 29.81
Nov 23, 2010 goldstein joseph l Director Option Execute 10,000 15.01 - 18.80
Nov 24, 2010 goldstein joseph l Director Automatic Sell 4,331 30.06
Aug 11, 2008 goldstein joseph l Director Acquisition (Non Open Market) 3,000 n/a
Aug 20, 2008 goldstein joseph l Director Disposition (Non Open Market) 2,500 n/a
Oct 1, 2008 goldstein joseph l Director Sell 500 22.32
May 14, 2010 goldstein joseph l Director Disposition (Non Open Market) 4,600 27.63
May 14, 2010 goldstein joseph l Director Option Execute 5,000 25.43
May 17, 2010 goldstein joseph l Director Sell 400 28.06
Showing 241-260 of 952 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)